Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$645M |
| 2 |
T-Mobile US
TMUS
|
+$640M |
| 3 |
AT&T
T
|
+$517M |
| 4 |
Humana
HUM
|
+$481M |
| 5 |
Boston Scientific
BSX
|
+$400M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.24B |
| 2 |
Apple
AAPL
|
+$755M |
| 3 |
Meta Platforms (Facebook)
META
|
+$707M |
| 4 |
Caterpillar
CAT
|
+$472M |
| 5 |
Advanced Micro Devices
AMD
|
+$449M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.33% |
| 2 | Technology | 3.2% |
| 3 | Financials | 2.22% |
| 4 | Industrials | 2.17% |
| 5 | Consumer Discretionary | 2.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3601
Clarus
CLAR
$140M
| $5.44M | ﹤0.01% |
575,794
-5,964
| -1% | -$56K |
|
3602
CALL
WEC Energy
WEC
$36B
| $5.44M | ﹤0.01% |
57,400
+5,300
| +10% | +$491K |
|
3603
Organogenesis Holdings
ORGO
$230M
| $5.44M | ﹤0.01% |
2,551,890
+1,876,307
| +278% | +$4.64M |
|
|
WBA
3604
DELISTED
Walgreens Boots Alliance
WBA
| $5.43M | ﹤0.01% |
157,143
-1,354,614
| -90% | -$48.1M |
|
3605
Expro Ltd
XPRO
$2.1B
| $5.43M | ﹤0.01% |
+295,906
| New | +$5.81M |
|
|
FTCH
3606
PUT
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
| $5.42M | ﹤0.01% |
1,104,800
+101,700
| +10% | +$552K |
|
|
XM
3607
DELISTED
Qualtrics International Inc. Class A Common Stock
XM
| $5.42M | ﹤0.01% |
304,037
-244,040
| -45% | -$3.73M |
|
3608
Privia Health
PRVA
$2.81B
| $5.42M | ﹤0.01% |
196,299
+108,761
| +124% | +$2.87M |
|
|
GES
3609
CALL
DELISTED
Guess Inc
GES
| $5.42M | ﹤0.01% |
278,400
-68,900
| -20% | -$1.48M |
|
3610
Direxion Daily Small Cap Bear 3x ETF
TZA
$196M
| $5.42M | ﹤0.01% |
17,396
+15,149
| +674% | +$4.51M |
|
3611
Ionis Pharmaceuticals
IONS
$9.51B
| $5.42M | ﹤0.01% |
151,523
-244,023
| -62% | -$9.16M |
|
3612
CALL
Host Hotels & Resorts
HST
$15.7B
| $5.42M | ﹤0.01% |
328,400
+77,400
| +31% | +$1.32M |
|
3613
PUT
GoPro
GPRO
$110M
| $5.41M | ﹤0.01% |
1,075,100
+446,600
| +71% | +$2.41M |
|
3614
Zumiez
ZUMZ
$314M
| $5.4M | ﹤0.01% |
293,084
+253,700
| +644% | +$5.84M |
|
3615
SK Telecom
SKM
$14.8B
| $5.4M | ﹤0.01% |
+263,303
| New | +$5.38M |
|
3616
CALL
Teva Pharmaceuticals
TEVA
$42.8B
| $5.39M | ﹤0.01% |
609,500
-1,566,700
| -72% | -$15.5M |
|
3617
PUT
Golar LNG
GLNG
$5.36B
| $5.39M | ﹤0.01% |
249,700
+40,600
| +19% | +$909K |
|
3618
Core & Main
CNM
$8.61B
| $5.39M | ﹤0.01% |
233,220
+30,180
| +15% | +$665K |
|
|
VRNA
3619
DELISTED
Verona Pharma
VRNA
| $5.39M | ﹤0.01% |
+268,248
| New | +$5.79M |
|
3620
Direxion Daily Energy Bull 2X ETF
ERX
$251M
| $5.38M | ﹤0.01% |
92,422
-20,629
| -18% | -$1.3M |
|
3621
CALL
JetBlue
JBLU
$2.13B
| $5.38M | ﹤0.01% |
739,500
-826,800
| -53% | -$6.53M |
|
3622
PUT
Shoals Technologies Group
SHLS
$1.42B
| $5.38M | ﹤0.01% |
236,200
+147,800
| +167% | +$3.65M |
|
3623
First Trust Cloud Computing ETF
SKYY
$3.31B
| $5.38M | ﹤0.01% |
80,419
-95,450
| -54% | -$6.01M |
|
3624
PUT
Virgin Galactic
SPCE
$503M
| $5.38M | ﹤0.01% |
66,385
-25,260
| -28% | -$2.52M |
|
3625
PUT
Frontier Group Holdings
ULCC
$1.54B
| $5.38M | ﹤0.01% |
546,300
+455,900
| +504% | +$5.09M |
|
Similar funds
Ken Griffin's Q1 2023 Portfolio in Review
As of Q1 2023, Ken Griffin held 16,292 positions worth $455B, up 6.2% from $428B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Ken Griffin withdrew a net $26.7B in Q1 2023, closing 1,652 positions and reducing 6,687 holdings. Its most notable exit was Restaurant Brands International, an estimated $93.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 3.3% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
Against the trend, Ken Griffin opened a new position in Keurig Dr Pepper worth $238M.
- Ken Griffin's largest Q1 2023 buy was Keurig Dr Pepper: 6,751,572 shares worth $238M.
- Ken Griffin added most to Invesco QQQ Trust in Q1 2023, an estimated $645M increase.
- Ken Griffin's biggest Q1 2023 reduction was Tesla, cutting an estimated $1.24B.
- Ken Griffin fully exited Restaurant Brands International in Q1 2023, selling an estimated $93.3M.
- Ken Griffin's ten largest holdings make up 33% of its $455B portfolio in Q1 2023.
- Ken Griffin opened 1,466 new positions and closed 1,652 in Q1 2023.
- Ken Griffin's portfolio value rose 6.2% quarter-over-quarter to $455B.
Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.